SCM
IMVT icon

Sterling Capital Management’s Immunovant IMVT Stock Holding History

Sterling Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Sell
300
-229
-43% -$6.98K ﹤0.01% 2144
2026
Q1 		$13.1K Buy
529
+75
+17% +$1.94K ﹤0.01% 2230
2025
Q4 		$11.5K Buy
454
+288
+173% +$6.42K ﹤0.01% 2535
2025
Q3 		$2.68K Buy
166
+1
+0.6% +$16 ﹤0.01% 2933
2025
Q2 		$2.64K Buy
165
+104
+170% +$1.57K ﹤0.01% 2839
2025
Q1 		$1.04K Buy
61
+4
+7% +$84 ﹤0.01% 2798
2024
Q4 		$1.41K Sell
57
-1
-2% -$28 ﹤0.01% 2869
2024
Q3 		$1.65K Buy
+58
New +$1.71K ﹤0.01% 2272

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's IMVT Position: Q2 2026 in Review

Sterling Capital Management reduced its Immunovant (IMVT) stake by 43% in Q2 2026, selling an estimated $6.98K and leaving 300 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2144.

Sterling Capital Management first reported a position in IMVT in Q3 2024 and has held it in 8 quarters since. The position peaked at $13.1K in Q1 2026. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Sterling Capital Management held 300 shares of Immunovant worth $11.6K as of Q2 2026.
  • Sterling Capital Management sold 229 Immunovant shares in Q2 2026, an estimated $6.98K.
  • Immunovant made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2144 holding.
  • Sterling Capital Management first reported a position in Immunovant in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Immunovant position peaked at $13.1K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.